On behalf of Cathay Life Insurance Co. Ltd., Cathay Financial Holdings announces the assignment performing lending assets.
2007-02-13
1.Name and nature of the subject matter (if preferred shares,
the terms and conditions of issuance shall also be indicated,
e.g.dividend yield):Participation in Chi Mei Optoeletronics syndication
2.Date of occurrence of the event:2007/02/13
3.Volume, unit price, and total monetary amount of the transaction:
participation amount & related fees totaled NT$335,050,000
4.Counterpart to the trade and its relationship to the Company
(if the trading counterpart is a natural person and furthermore
is not an actual related party of the Company, the name of the
trading counterpart is not required to be disclosed):Calyon Corporate
and Investment Bank Ltd. Taipei Brench.
5.Where the counterpart to the trade is an actual related party,
a public announcement shall also be made of the reason for choosing
the related party as trading counterpart and the identity of the
previous owner (including its relationship with the company and the
trading counterpart), price of transfer, and date of acquisition:
not applicable.
6.Where a person who owned the property within the past five years
has been an actual related person of the company, a public
announcement shall also include the dates and prices of
acquisition and disposal by the related person and the
person’s relationship to the company at those times:not applicable.
7.Matters related to the creditor's rights currently being disposed
of (including types of collateral of the disposed creditor's rights;
if the creditor's rights are creditor's rights toward a related
person, the name of the related person and the book amount of the
creditor's rights toward such related person currently being
disposed of must also be announced):securities of the lending assets are
plants and equipments.However, it is a syndication loan and we share the
income in compliance with the agreement that signed with Calyon.
8.Anticipated profit or loss from the disposal (not applicable in
cases of acquisition of securities) (where originally deferred, the
status or recognition shall be stated and explained):none.
9.Terms of delivery or payment (including payment period and
monetary amount), restrictive covenants in the contract, and
other important stipulations:in compliance with the loan agreement
of the syndication.
10.The manner in which the current transaction was decided, the
reference basis for the decision on price, and the decision-making
department:approval from the President of related terms and conditions are in
accordance with the loan agreement and common market practices.
No preferential treatment.
11.Current cumulative volume, amount, and shareholding percentage
of holdings of the security being traded (including the current
trade) and status of any restriction of rights (e.g.pledges):not applicable.
12.Current ratio of long or short term securities investment
(including the current trade) to the total assets and shareholder's
equity as shown in the most recent financial statement and the
operating capital as shown in the most recent financial statement:not
applicable.
13.Broker and broker's fee:not applicable.
14.Concrete purpose or use of the acquisition or disposition:in compliance
with Insurance Law,legal use of the insurance funds.
15.Net worth per share of company underlying securities acquired
or disposed of:not applicable.
16.Do the directors have any objection to the present transaction?:none.
17.Has the CPA issued an opinion on the unreasonableness of the price
of the current transaction?:none.
18.Any other matters that need to be specified:none.
